Oscar Health is breaking out. EPS just jumped 164% year over year. Quarterly revenue passed $3 billion. Cash on hand totals $4.9 billion. Insiders are buying millions.
Oscar Health is being priced like an afterthought and performing like a breakout. The Q1 numbers confirm it, the insider trades back it, and the float is moving. This isn’t crowd hype. It’s internal conviction and raw financials that are … Read more